Synapse - Joachim Yahalom

Search Within

Joachim Yahalom

Results (625)

Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2

Meeting Abstract

Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
Blood (2022)

Fulltext@MSK | Save

Initial treatment response is prognostic and predictive of relapse patterns: Outcomes of >500 patients treated for primary CNS lymphoma

Meeting Abstract

Tringale, K. R.; Yahalom, J.; Scordo, M.; Cederquist, G. Y.; Vachha, B.; Schaff, L.; Hajj, C.; Hubbeling, H.; Zhang, Z.; White, C.; more...
Blood (2022)

Fulltext@MSK | Save

Identifying patterns of failure after initial therapy in primary CNS lymphoma in a large patient cohort

Meeting Abstract

Tringale, K.; Yahalom, J.; Scordo, M.; Vachha, B.; Schaff, L.; Grommes, C.; Imber, B.
Neuro-Oncology (2022)

Fulltext@MSK | Save

Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma

Meeting Abstract

Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Outcomes and failure patterns for >500 patients treated for primary CNS lymphoma: Exploring modern roles for radiotherapy

Meeting Abstract

Tringale, K. R.; Yahalom, J.; Vachha, B.; Hajj, C.; Hubbeling, H. G.; Grommes, C.; Imber, B. S.
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Radiotherapy for relapse after chimeric antigen receptor T cell therapy in hematologic malignancies

Meeting Abstract

Hubbeling, H. G.; Silverman, E. A.; Alarcon Tomas, A.; Tringale, K. R.; Wijetunga, N. A.; Hajj, C.; Mailankody, S.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Predictors of response to radiation therapy and of progression to multiple myeloma in patients with solitary bone and solitary extramedullary plasmacytomas

Meeting Abstract

Fregonese, B.; Imber, B. S.; Lee, J.; Yahalom, J.; Hajj, C.
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015)

Journal Article

Wu, Y.; Liu, X.; Imber, B. S.; Zhong, Q. Z.; Yang, Y.; Wu, T.; Chen, S. Y.; Chen, B.; Song, Y. W.; Fang, H.; more...
Radiotherapy and Oncology (2022)

Fulltext@MSK | Save

Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies

Meeting Abstract

Imber, B. S.; Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Alarcon Tomas, A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy

Meeting Abstract

Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Tomas, A. A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save